Entero Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Entero Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2015 to Q3 2024.
  • Entero Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $1K, a 85.7% decline year-over-year.
  • Entero Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $22K.
  • Entero Therapeutics, Inc. annual Depreciation for 2023 was $29.3K, a 0.01% increase from 2022.
  • Entero Therapeutics, Inc. annual Depreciation for 2022 was $29.3K, a 99% increase from 2021.
  • Entero Therapeutics, Inc. annual Depreciation for 2021 was $14.7K, a 61.1% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $22K $1K -$6K -85.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $28K $5.5K -$1.8K -24.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-21
Q1 2024 $29.8K $7.78K +$479 +6.56% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $29.3K $7.67K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $7K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $7.3K Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-21
Q1 2023 $7.3K -$17 -0.23% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $21K $7.32K +$6.3K +617% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $14.7K $5.69K -$5.45K -48.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $20.2K $6K -$2K -25% Jul 1, 2021 Sep 30, 2021 10-Q/A 2021-11-16
Q2 2021 $22.2K $2K -$7K -77.8% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $29.2K $1.02K -$8.64K -89.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 $37.8K $11.1K -$699 -5.91% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $38.5K $8K -$9.22K -53.5% Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-11-16
Q2 2020 $47.7K $9K -$7.93K -46.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $55.6K $9.66K -$7.45K -43.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 $63.1K $11.8K -$4K -25.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $67.1K $17.2K +$1.57K +10% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $65.5K $16.9K +$1.27K +8.11% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $64.3K $17.1K +$2.35K +15.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $61.9K $15.8K +$2.17K +15.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $59.7K $15.7K +$2.93K +23% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $56.8K $15.7K +$3.13K +25% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $53.7K $14.8K +$4.17K +39.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $49.5K $13.7K +$2.46K +22% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $47.1K $12.7K +$1.56K +14% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $45.5K $12.5K +$1.44K +13% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $44.1K $10.6K -$248 -2.29% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $44.3K $11.2K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $11.2K +$2.46K +28.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $11.1K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $10.8K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q3 2015 $8.71K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.